Loading
SP
Synergy Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by JACOB GARY S, was filed 30 May 2017.
Synergy Pharmaceuticals, Inc.: what insiders have been doing
Synergy Pharmaceuticals, Inc. is a listed company. Its insiders report their share dealings to SEC (Form 4). No insider at Synergy Pharmaceuticals, Inc. has published a filing in the past twelve months. The most recent one dates from 16 August 2018.
Our records for Synergy Pharmaceuticals, Inc. go back to 2016, with 2 purchases and 9 sales on the open market in total.
Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
23
Thresholds
n/a
Buy Volume
€38,649
2 ops. · all time
Sell Volume
€39M
9 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2010FY ended December 2010 · cache
Income statement
Gross profit7.1M
Net income-13.6M
Last declaration on 16 August 2018
Declarations23 total
101,695 shares0Common StockSEC:0001104659-18-052475:1
150,000 shares@ US$1.20100.0% of flowCommon StockSEC:0001104659-18-052475:0
27,785 shares0Common StockSEC:0001104659-18-044168:1
13,896 shares0Common StockSEC:0001104659-18-044167:1
100,023 shares@ US$0.50100.0% of flowCommon StockSEC:0001104659-18-044168:0
50,023 shares@ US$0.5051.3% of flowCommon StockSEC:0001104659-18-044167:0
474,961 shares@ US$0.5092.0% of flowCommon StockSEC:0001104659-18-040813:0
131,934 shares0Common StockSEC:0001104659-18-040813:1
150,246 shares0Common StockSEC:0001104659-18-040813:2
50,000 shares@ US$0.5023.7% of flowCommon StockSEC:0001104659-18-021838:0
8,750,000 shares@ US$2.8253.7% of flowCommon stock, par value of $.0001SEC:0001140361-17-042821:0
87 shares@ US$3.780.0% of flowCommon stock, par value of $.0001SEC:0001140361-17-030933:0
26,200 shares@ US$3.770.2% of flowCommon stock, par value of $.0001SEC:0001140361-17-030933:1
5,680 shares@ US$3.528.0% of flowCommon StockSEC:0001104659-17-035883:0
Canonical exit: 24 Aug 2017 (T+90)
6,500 shares@ US$3.5924.3% of flowCommon StockSEC:0001104659-17-035885:0
Canonical exit: 24 Aug 2017 (T+90)
140,000 shares@ US$4.241.4% of flowCommon stock, par value of $.0001SEC:0001140361-16-085412:0
33,600 shares@ US$5.750.4% of flowCommon stock, par value of $.0001SEC:0001140361-16-081083:0
20,700 shares@ US$5.600.3% of flowCommon stock, par value of $.0001SEC:0001140361-16-081083:1
1,439 shares@ US$4.616.9% of flowCommon StockSEC:0001104659-16-145907:0
2,518 shares@ US$5.7615.1% of flowCommon StockSEC:0001104659-16-145907:2
1,079 shares@ US$4.284.8% of flowCommon StockSEC:0001104659-16-145907:1
1,973,713 shares@ US$5.6125.0% of flowCommon stock, par value of $.0001SEC:0001140361-16-080344:0
1,500,000 shares@ US$5.6119.1% of flowCommon stock, par value of $.0001SEC:0001140361-16-080344:1
23 of 23 declarations
About Synergy Pharmaceuticals, Inc.
Synergy Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing treatments for gastrointestinal diseases. It aims to innovate in the field of medications to enhance patients' quality of life.
